LINC01214: A Potential Drug Target and Biomarker for Diseases

Target Name: LINC01214

NCBI ID: G101928022

LINC01214

Other Name(s): Long intergenic non-protein coding RNA 1214, transcript variant 1 | long intergenic non-protein coding RNA 1214

LINC01214: A Potential Drug Target and Biomarker for Diseases

LINC01214 is a non-protein coding RNA (ncRNA) molecule located within the intron of the gene ZNF213. It has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

The ZNF213 gene is located on chromosome 16 and encodes for a protein known as ZNF213, which is a critical regulator of stem cell proliferation and differentiation. The ZNF213 protein has been shown to play a role in the development and progression of several diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

LINC01214 is a non-coding RNA molecule that is located within the intron of the ZNF213 gene. It has been shown to interact with the ZNF213 protein and can modulate the activity of the ZNF213 protein.

Studies have shown that LINC01214 is expressed in a variety of tissues and cells, including stem cells, neurons, and tissues derived from the brain. It has also been shown to be involved in several cellular processes, including cell growth, cell cycle progression, and protein synthesis.

In addition to its role in cellular processes, LINC01214 has also been shown to play a role in the development and progression of several diseases. For example, LINC01214 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. It has also been shown to be involved in the development of cancer, and to contribute to the development of certain psychiatric disorders.

Despite its potential as a drug target and biomarker, much research is still needed to fully understand the role of LINC01214 in disease. However, its potential as a drug target is significant, and further studies are being conducted to investigate its potential as a therapeutic agent.

In conclusion, LINC01214 is a non-protein coding RNA molecule that has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Further research is needed to fully understand its role in disease and to develop safe and effective therapies based on its properties.

Protein Name: Long Intergenic Non-protein Coding RNA 1214

The "LINC01214 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01214 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets